ALDURAZYME
laronidase
Listed by Genzyme Corporation
- Strength
- 2.9 mg/5mL
- Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Class
- Hydrolytic Lysosomal Glycosaminoglycan-specif…
What it contains
- Laronidase 2.9 mg/5mL
FDA record
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Drug class | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme |
| Approval route | BLA — biologic licence |
| NDC code | 58468-0070 |
| FDA application | BLA125058 |
| RxNorm concept | 403822 |
| Package sizes listed | 1 |
| Marketed since | April 2003 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.